Position in LQDA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,043,054
+$2,688,946 QoQ
Shares Held
372,100
+13.0% QoQ
Ownership
0.418%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026OBERWEIS ASSET MANAGEMENT INC/ holds $92,494,217 across 6 Drug Manufacturers - Specialty & Generic names. LQDA ranks #5 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
653,413 | $19,916,028 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
221,386 | $17,024,583 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
318,634 | $15,342,227 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
277,100 | $15,326,401 | |
| 5 | LQDA |
Liquidia Corp
This page
|
372,100 | $14,043,054 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
439,300 | $10,841,924 |
All Filings in LQDA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,043,054 | 372,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,354,108 | 329,200 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,304,088 | 321,200 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $4,002,152 | 321,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,700,775 | 250,900 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,950,584 | 250,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,509,000 | 250,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,198,400 | 183,200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,212,500 | 150,000 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||